The role of molecular imaging in the assessment of cardiac amyloidosis: state-of-the-art.
CONCLUSION: Molecular imaging represent a sensitive tool for early assessment of both amyloid burden and cardiac innervation, to differentiate between subtypes and to monitor disease burden, disease progression, and potential response to therapy.
PMID: 32525789 [PubMed - as supplied by publisher]
Source: Current Radiopharmaceuticals - Category: Radiology Tags: Curr Radiopharm Source Type: research
More News: Amyloidosis | Arrhythmia | Cardiology | Cardiomyopathy | Databases & Libraries | Electrocardiogram | Heart | Heart Failure | MRI Scan | PET Scan | Radiology | Restrictive Cardiomyopathy | SPECT | Study